scispace - formally typeset
C

Callum J. Bell

Researcher at National Center for Genome Resources

Publications -  48
Citations -  7502

Callum J. Bell is an academic researcher from National Center for Genome Resources. The author has contributed to research in topics: Genome & Gene mapping. The author has an hindex of 29, co-authored 47 publications receiving 6926 citations. Previous affiliations of Callum J. Bell include National Institute for Basic Biology, Japan & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Assignment of 30 Microsatellite Loci to the Linkage Map of Arabidopsis

TL;DR: After the presence of microsatellites in Arabidopsis and their utility for genetic mapping had been demonstrated, systematic screening for (CA)n and (GA)n sequences was carried out on marker-selected plasmid libraries and a small-insert genomic library.
Journal ArticleDOI

Requirement of the Auxin Polar Transport System in Early Stages of Arabidopsis Floral Bud Formation.

TL;DR: It is suggested that the normal level of polar transport activity in the inflorescence axes is required in early developmental stages of floral bud formation in Arabidopsis and that the primary function of the pin1 gene is auxin polar transport in the inforescence axis.
Journal ArticleDOI

The Marine Microbial Eukaryote Transcriptome Sequencing Project (MMETSP): Illuminating the Functional Diversity of Eukaryotic Life in the Oceans through Transcriptome Sequencing

Patrick J. Keeling, +89 more
- 24 Jun 2014 - 
TL;DR: In this paper, the authors describe a resource of 700 transcriptomes from marine microbial eukaryotes to help understand their role in the world's oceans and their biology, evolution, and ecology.
Journal ArticleDOI

Carrier Testing for Severe Childhood Recessive Diseases by Next-Generation Sequencing

TL;DR: This study provides a proof of concept that it should be possible to introduce preconception carrier screening for many recessive pediatric disease mutations as long as the disease genes are known and predicts that the screening test could be made faster and more cost-effective with the advent of microdroplet polymerase chain reaction and third-generation sequencing technologies.